Effect of oral administration of epsilon-aminocaproic acid on serum lipids in patients with nephrotic syndrome
Markiewicz, K.; Walasek, L.
Polski Tygodnik Lekarski 28(29): 1097-1100
1973
ISSN/ISBN: 0032-3756 PMID: 4728793 Document Number: 57800
Document emailed within 1 workday
Related Documents
Pleissner, K. 1971: Epsilon-aminocaproic acid--a new therapeutic agent in dysmenorrhea and the premenstrual syndrome Geburtshilfe und Frauenheilkunde 31(7): 683-686Pliaĭsner, K. 1971: Experience in the treatment of dysmenorrhea and the premenstrual syndrome with epsilon-aminocaproic acid Akusherstvo i Ginekologiia 47(8): 75
Howorka, E.; Wyrzykiewicz, T. 1970: Administration of epsilon-aminocaproic acid (EACA) in the prevention of fibrinolytic hemorrhages associated with the expulsion of the fetus remaining in the uterus after its death Wiadomosci Lekarskie 23(11): 973-977
Shlygina, O.E. 1973: Effect of epsilon-aminocaproic acid on the accumulation of labeled fibrinogen I-131 in the transplantable tumor IMP-1 Voprosy Onkologii 19(7): 58-62
Haidet, K.K. 1995: Aminocaproic acid (epsilon aminocaproic acid) (Amicar) Neonatal Network: Nn 14(3): 75-77
Modugno, P. 1983: The effect of epsilon-aminocaproic acid on the normalization of embolizing fatty matter in the rabbit lung following experimental fractures. a polarized light study Archivio Per le Scienze Mediche 140(2): 159-164
Maineri, P.; Covaia, G.; Realini, M.; Caccia, G.; Ucussich, E.; Luraschi, M.; Crosta, A.; Foresti, B.; Chiaranda, M. 2000: Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid Minerva Cardioangiologica 48(6): 155-160
Marmo, E.; Ungaro, B.; Giordano, L. 1971: On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid) Minerva Cardioangiologica 19(2): 86-115
Arora, S.; Arora, R.C.; Garg, R.K.; Agarwal, N.; Nautiyal, A. 1988: Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins Indian Journal of Physiology and Pharmacology 32(1): 67-71
Hureau, J.; Vairel, E.; Martin, E.; Vayre, P. 1966: Comparative study of some properties of the sodium salt of N-acetyl-amino-6-hexanoic acid and epsilon-aminocaproic acid Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 160(4): 746-748
Klimek, R.; Stanek, J. 1975: Epsilon-aminocaproic acid in the treatment of abortion Ginekologia Polska 46(7): 747-750
Morris, C.D.; Jacobs, P.; Berman, P.A.; Rutherfoord, G.S. 1983: Epsilon-aminocaproic acid-induced myopathy. A case report South African Medical Journal 64(10): 363-366
Eneroth, G.; Grant, C.A. 1966: Epsilon aminocaproic acid and reduction in fertility of male rats Acta Pharmaceutica Suecica 3(2): 115-122
Zatikian, L.O. 1975: Epsilon-aminocaproic acid as an anti-allergic agents in surgical practice Klinicheskaia Meditsina 53(11): 103-106
Chowdhary, U.M.; Carey, P.C.; Hussein, M.M. 1979: Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid Lancet 1(8119): 741-743
Purwin, M.; Bruzgo, I.; Markowska, A.; Midura-Nowaczek, K. 2009: Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors Die Pharmazie 64(11): 765-767
Liskiewicz, Z.; Maj, S.; Ziemski, J.M. 1971: Renal complications during treatment of hematuria in hemophilia a with epsilon-aminocaproic acid (EACA) Polski Tygodnik Lekarski 26(4): 145-147
Coste, F.; Tremolières, F.; Bousquet, M.; Martin, E.; Dreyfuss, D.; Levesque, M.; Barge, J. 1985: Fatal massive intravascular coagulation during phlebography. Responsibility of epsilon-aminocaproic acid? Presse Medicale 14(15): 832-834
Buşilă, V.T.; Mârza, A.; Dragomirescu, M.; Marţincu, V.; Stănescu-Lupu, D.; Novac, E. 1970: Comparative action of hydrocortisone hemisuccinate and epsilon-aminocaproic acid in experimental endotoxic shock Medicina Interna 22(3): 361-370
Garrett, J.; Branco, D. 1973: Indirect sympathomimetic actions of epsilon-aminocaproic acid (EACA): role of the adrenal medulla Archives Internationales de Pharmacodynamie et de Therapie 204(2): 252-259